News

Basilea has presents new research data on its anti-tumor drug candidate BAL27862 at the international conference on Molecular Targets and Cancer Therapeutics in Boston (MA). The new data

Unilife Medical Solutions has appointed Mikron as its contracted supply partner for the development and supply of automated assembly systems to support the commercial production of the Unifill

FDA has accepted Actelion’s supplemental new drug application (sNDA) for an extension of indication for Zavesca (Miglustat) for the treatment of progressive neurological manifestations in adult and pediatric

Ecron Acunova, a full-service clinical research organization (CRO), has opened a new office in Moscow, Russia in October 2009. Galyna Andriyko has been named as General Manager. She

GlaxoSmithKline (GSK) seeks to shift a part of its Relenza drug manufacturing operations to China. The company’s strategic intent is to make available its flu drug, Relenza to

AstraZeneca has submitted a New Drug Application (NDA) to the FDA for Ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients

The US House of Representatives has passed the Chemical and Water Security Act of 2009 (HR 2868) by 230 to 193 votes. Over 21 Democrats joined all 172

As part of the agreement, Asuragen will pursue CE marked-IVD registration in Europe and regulatory clearance in the US. The diagnostic test will then be distributed by Life

Three five-part hematology analyzers were featured at the company’s stand in Hall 03 covering the range of laboratory needs from the manual BC-5300, to the mid-line automated BC-5380